Prothena Corporation plc
PRTA
$9.70
$0.050.52%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 47.92% | -5.41% | 276.98% | 62.51% | 69.50% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 47.92% | -5.41% | 276.98% | 62.51% | 69.50% |
| Cost of Revenue | 0.88% | 19.78% | 36.02% | 56.76% | 62.71% |
| Gross Profit | 32.38% | -84.86% | 79.83% | -53.54% | -58.22% |
| SG&A Expenses | 8.67% | 15.98% | 25.88% | 26.56% | 23.92% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.59% | 18.91% | 33.68% | 49.12% | 52.27% |
| Operating Income | 19.09% | -49.37% | 47.26% | -44.22% | -45.21% |
| Income Before Tax | 19.66% | -61.87% | 60.07% | -34.73% | -27.77% |
| Income Tax Expenses | 50.79% | 38.28% | 18.65% | -28.74% | -55.41% |
| Earnings from Continuing Operations | 16.81% | -80.09% | 63.85% | -35.19% | -25.72% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 16.81% | -80.09% | 63.85% | -35.19% | -25.72% |
| EBIT | 19.09% | -49.37% | 47.26% | -44.22% | -45.21% |
| EBITDA | 19.17% | -49.65% | 47.57% | -44.33% | -45.33% |
| EPS Basic | 17.84% | -77.70% | 65.67% | -23.02% | -10.63% |
| Normalized Basic EPS | 20.64% | -59.30% | 62.10% | -22.67% | -12.55% |
| EPS Diluted | 17.79% | -73.79% | 63.98% | -23.49% | -11.07% |
| Normalized Diluted EPS | 20.42% | -57.79% | 60.36% | -23.35% | -13.29% |
| Average Basic Shares Outstanding | 1.05% | 3.27% | 6.52% | 9.63% | 12.35% |
| Average Diluted Shares Outstanding | -0.43% | -0.64% | 6.70% | 9.11% | 11.73% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |